Skip to content
HowShorted

NEOPHOTONICS CORP short interest in 2018

In 2018, NEOPHOTONICS CORP's disclosed short interest ran from 18.47% of shares outstanding on 12 Jan 2018 to 11.38% on 31 Dec 2018, a change of -7.09 percentage points. The year's high was 22.02% on 30 Apr 2018 and its low 10.91% on 30 Nov 2018, averaging 16.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.58 days on 13 Jul 2018. Full history: NEOPHOTONICS CORP.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for NEOPHOTONICS CORP in 2018

2018 in figures

Start of year
18.47% (12 Jan 2018)
End of year
11.38% (31 Dec 2018)
Change
-7.09 pp
High
22.02% (30 Apr 2018)
Low
10.91% (30 Nov 2018)
Average
16.36%
Highest days to cover
23.58 (13 Jul 2018)
SEC filings marked
9

Every report in 2018

NEOPHOTONICS CORP short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201818.47%12.81
31 Jan 201818.75%10.95
15 Feb 201818.88%9.58
28 Feb 201817.70%9.94
15 Mar 201818.83%6.09results (8-K), 10-K filed
29 Mar 201819.81%7.87
13 Apr 201821.50%12.07
30 Apr 201822.02%6.42results (8-K)
15 May 201820.87%8.56results (8-K), 10-Q filed
31 May 201818.36%9.18
15 Jun 201817.14%13.63
29 Jun 201818.66%14.75
13 Jul 201817.19%23.58
31 Jul 201815.96%15.30
15 Aug 201814.38%4.4310-Q filed, results (8-K)
31 Aug 201814.07%10.08
14 Sep 201814.25%12.82
28 Sep 201814.02%10.43
15 Oct 201813.05%12.34
31 Oct 201812.86%9.85
15 Nov 201811.37%5.67results (8-K), 10-Q filed
30 Nov 201810.91%8.09
14 Dec 201812.20%5.12
31 Dec 201811.38%8.07

See also: NEOPHOTONICS CORP's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.